Digital CBT-I for Chronic Insomnia
A Multi-Site, Randomized, Wait-List Controlled Trial to Assess the Effectiveness and Safety of Digital Cognitive Behavioral Therapy for Insomnia (CBT-I) in Patients with Chronic Insomnia
1 other identifier
interventional
120
1 country
5
Brief Summary
This study evaluates the effectiveness and safety of a digital Cognitive Behavioral Therapy program for Insomnia (CBT-I) in individuals with chronic insomnia. Participants will be randomly assigned to either begin digital CBT-I immediately or join a wait-list.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2025
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 13, 2024
CompletedFirst Posted
Study publicly available on registry
November 19, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedNovember 19, 2024
November 1, 2024
10 months
November 13, 2024
November 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change from Baseline in Insomnia Severity Index (ISI) Score at Post-Intervention
The Insomnia Severity Index (ISI) measures the severity of insomnia symptoms, with scores ranging from 0 to 28. Higher scores indicate more severe insomnia, with 0-7 representing no clinically significant insomnia, 8-14 mild insomnia, 15-21 moderate insomnia, and 22-28 severe insomnia. This outcome measures the change in ISI score from baseline to 6 weeks, comparing changes between the digital CBT-I group and the waitlist control group.
"From baseline (Visit 1) to post-intervention assessment at 6 weeks
Secondary Outcomes (10)
Change from Baseline in Dysfunctional Beliefs and Attitudes about Sleep (DBAS-16) Score at Post-Intervention (6 Weeks)
From baseline to 6 weeks post-intervention
Change from Baseline in Epworth Sleepiness Scale (ESS) Score at Post-Intervention (6 Weeks)
From baseline to 6 weeks post-intervention
Change from Baseline in Patient Health Questionnaire-9 (PHQ-9) Score at Post-Intervention (6 Weeks)
From baseline to 6 weeks post-intervention
Change from Baseline in Generalized Anxiety Disorder-7 (GAD-7) Score at Post-Intervention (6 Weeks)
From baseline to 6 weeks post-intervention
Change from Baseline in Quality of Life (SF-36) Score at Post-Intervention (6 Weeks)
From baseline to 6 weeks post-intervention
- +5 more secondary outcomes
Other Outcomes (1)
System Usability Scale (SUS) Score for Digital CBT-I at Post-Intervention (6 Weeks)
6 weeks post-intervention
Study Arms (2)
digital CBT-I
EXPERIMENTALWaitlist Control
NO INTERVENTIONInterventions
The intervention is a digital Cognitive Behavioral Therapy for Insomnia (CBT-I) program, delivered via a mobile application. The program includes structured, self-guided modules focusing on sleep hygiene education, cognitive restructuring, stimulus control, bed time restriction, and relaxation techniques. Each module offers interactive exercises and weekly assignments designed to support behavior change and improve sleep. Participants will receive app-based reminders to encourage regular engagement, with features for tracking progress and adherence throughout the 6 week program.
Eligibility Criteria
You may qualify if:
- Meets diagnostic criteria for insomnia disorder according to the International Classification of Diseases, 10th Revision (ICD-10), including: F51: Nonorganic sleep disorders; G47: Sleep disorders
- Has experienced insomnia symptoms for 3 months or longer.
- Scores 8 or higher on the Insomnia Severity Index (ISI).
- Oral and written fluency in Korean
- Owns a smartphone and is independently able to use apps on a smartphone.
- Voluntarily agrees to participate in this clinical study and provides signed informed consent.
You may not qualify if:
- Currently receiving non-pharmacological treatments for insomnia (e.g., CBT-I, light therapy, traditional medicine for sleep) within the past 3 months from screening.
- Diagnosed with other sleep disorders aside from insomnia and currently symptomatic, such as:
- Obstructive sleep apnea (G47.30)
- Sleep behavior disorders
- Restless leg syndrome (G28.8)
- Narcolepsy (G47.4)
- Has an active, ongoing physical illness that impedes daily functioning, such as:
- Congestive heart failure
- Chronic obstructive pulmonary disease (COPD)
- Acute pain
- Neurological disorders (e.g., cerebrovascular disease)
- Neurodegenerative disorders (e.g., dementia, multiple sclerosis)
- Unstable medical conditions or life expectancy of less than 6 months
- Adjustments in schedule or dosage of sleep medications, antidepressants, anticonvulsants, anxiolytics, or antipsychotics within the past 3 months, or use of PRN (as needed) prescribed sleep medications.
- Engaged in shift work.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- WELT corplead
Study Sites (5)
Inje University Ilsan Paik Hospital
Goyang-si, Gyeonggi-do, 10380, South Korea
Yongin Severance Hospital
Yongin-si, Gyeonggi-do, 16995, South Korea
Severance Hospital, Yonsei University Health System
Seoul, Seoul, 03722, South Korea
The Catholic University of Korea, Seoul ST. Mary's Hospital
Seoul, Seoul, 06591, South Korea
Ewha Womans University Medical Center
Seoul, Seoul, 07804, South Korea
Related Publications (1)
Moon DU, Kim J, Sun JH, Lee Y. Applying a mobile intervention for chronic insomnia in routine care: Study protocol for a multicenter randomized controlled trial. Internet Interv. 2025 Jun 20;41:100848. doi: 10.1016/j.invent.2025.100848. eCollection 2025 Sep.
PMID: 40636932DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2024
First Posted
November 19, 2024
Study Start
January 1, 2025
Primary Completion
November 1, 2025
Study Completion
March 1, 2026
Last Updated
November 19, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share